• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩洛哥心血管疾病的流行病学:系统评价。

Epidemiology of Cardiovascular Diseases in Morocco: A Systematic Review.

机构信息

Laboratory of Genetics and Biometry. Faculty of Science. Ibn Tofail University. Kenitra. Morocco.

出版信息

Rev Diabet Stud. 2021 Nov 1;17(2):57-67. doi: 10.1900/RDS.2021.17.57.

DOI:10.1900/RDS.2021.17.57
PMID:34852896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9380084/
Abstract

To provide a systematic review of studies on cardiovascular diseases (CVD) and their risk factors in the Moroccan population. A systematic analysis was performed based on PRISMA guidelines by retrieving data bases (Medline, Embase, and other) using technical keywords in addition to manual research on official websites. Published studies in the English or French language, conducted in Morocco or concerning the Moroccan population within the last two decades, were identified. This is the first systematic review of CVD in Morocco. Data from 159 studies were retrieved and analyzed. Most studies were written in the English language (75.89%) and published between 2010 and 2019 (85.47%). The mortality rate caused by CVD in Morocco has reached 38%, with ischemic heart disease and stroke as the main events causing death (31.0% and 22.5% respectively). The risk factors present in the population studied were headed by tobacco smoking (45- 50%), followed by physical inactivity (21.1%), elevated rate of hypertension (25.3%), and depression (5.47%). Impacted by a high rate of illiteracy and poverty and an unprepared health care system in Morocco, these numbers are expected to increase over the next decade. Based on these alarming incidences, investment in scientific research and epidemiological studies should be increased to determine the needs of the local population. The available evidence shows that the risk of cardiovascular disease and the associated mortality is very high in Morocco and will rise in the next years prospectively, which calls for urgent multi-sectorial approaches and treatment strategies.

摘要

为了对摩洛哥人群中心血管疾病(CVD)及其危险因素的研究进行系统综述。根据 PRISMA 指南,通过检索 Medline、Embase 和其他数据库(使用技术关键词)并结合官方网站的手动检索,进行了系统分析。识别出过去 20 年内在摩洛哥或涉及摩洛哥人群的以英语或法语发表的研究。这是摩洛哥 CVD 的首次系统综述。检索和分析了 159 项研究的数据。大多数研究以英语撰写(75.89%),发表于 2010 年至 2019 年(85.47%)。摩洛哥 CVD 的死亡率达到 38%,缺血性心脏病和中风是主要死亡原因(分别为 31.0%和 22.5%)。研究人群中的危险因素以吸烟(45-50%)为首,其次是缺乏身体活动(21.1%)、高血压发病率高(25.3%)和抑郁(5.47%)。摩洛哥的高文盲率和贫困率以及准备不足的医疗保健系统对此产生影响,预计未来十年这些数字将增加。鉴于这些令人震惊的情况,应增加对科学研究和流行病学研究的投资,以确定当地人口的需求。现有证据表明,摩洛哥心血管疾病的风险和相关死亡率非常高,并将在未来几年内上升,这需要紧急采取多部门方法和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/dc5b997c7e6f/RDS-17-057-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/18049fad187a/RDS-17-057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/2b122bfad61f/RDS-17-057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/b8f51f910cf0/RDS-17-057-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/dc5b997c7e6f/RDS-17-057-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/18049fad187a/RDS-17-057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/2b122bfad61f/RDS-17-057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/b8f51f910cf0/RDS-17-057-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ac/9380084/dc5b997c7e6f/RDS-17-057-g004.jpg

相似文献

1
Epidemiology of Cardiovascular Diseases in Morocco: A Systematic Review.摩洛哥心血管疾病的流行病学:系统评价。
Rev Diabet Stud. 2021 Nov 1;17(2):57-67. doi: 10.1900/RDS.2021.17.57.
2
Cardiovascular risk factors in Moroccan women: systematic review and meta-analysis.摩洛哥女性心血管危险因素:系统评价和荟萃分析。
BMC Public Health. 2024 Sep 3;24(1):2390. doi: 10.1186/s12889-024-19950-4.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Ischemic stroke in Morocco: a systematic review.摩洛哥的缺血性中风:一项系统综述。
BMC Neurol. 2019 Dec 30;19(1):349. doi: 10.1186/s12883-019-1558-1.
5
Understanding of and perceptions towards cardiovascular diseases and their risk factors: a qualitative study among residents of urban informal settings in Nairobi.理解和认识心血管疾病及其危险因素:在内罗毕城市非正规住区居民中的定性研究。
BMJ Open. 2019 Jun 16;9(6):e026852. doi: 10.1136/bmjopen-2018-026852.
6
Prevalence of type 2 diabetes mellitus, other cardiovascular risk factors, and cardiovascular disease in Turkish and Moroccan immigrants in North West Europe: a systematic review.西北欧土耳其和摩洛哥移民中2型糖尿病、其他心血管危险因素及心血管疾病的患病率:一项系统评价
Prev Med. 2004 Dec;39(6):1068-76. doi: 10.1016/j.ypmed.2004.04.009.
7
Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000.2000年摩洛哥主要心血管危险因素的患病率:一项全国性调查结果
J Hypertens. 2003 May;21(5):897-903. doi: 10.1097/00004872-200305000-00013.
8
Obesity and cardiovascular disease risk among Turkish and Moroccan migrant groups in Europe: a systematic review.肥胖与欧洲土耳其和摩洛哥移民群体中的心血管疾病风险:系统综述。
Obes Rev. 2012 Jan;13(1):2-16. doi: 10.1111/j.1467-789X.2011.00932.x. Epub 2011 Sep 26.
9
Prevalence and risk factors of chronic complications among patients with type 2 diabetes mellitus in Morocco: a cross-sectional study.摩洛哥 2 型糖尿病患者慢性并发症的患病率及其危险因素:一项横断面研究。
Pan Afr Med J. 2022 Mar 8;41:182. doi: 10.11604/pamj.2022.41.182.25532. eCollection 2022.
10
[Epidemiology and management of heart failure in a Moroccan center].[摩洛哥某中心心力衰竭的流行病学与管理]
Pan Afr Med J. 2016 May 27;24:85. doi: 10.11604/pamj.2016.24.85.8521. eCollection 2016.

引用本文的文献

1
Mid-life association between cardiovascular risk factors and cerebral blood flow in a multi-ethnic population.多族裔人群中心血管危险因素与脑血流量的中年期关联。
Cereb Circ Cogn Behav. 2025 Apr 5;8:100384. doi: 10.1016/j.cccb.2025.100384. eCollection 2025.
2
A Moroccan Experience in the Management of Acute Coronary Syndrome Without ST-Segment Elevation: Clinical Profiles and Therapeutic Approaches.摩洛哥非ST段抬高型急性冠状动脉综合征管理经验:临床特征与治疗方法
Cureus. 2025 Mar 6;17(3):e80155. doi: 10.7759/cureus.80155. eCollection 2025 Mar.
3
Effects of L. Bract Extract on Lipid Metabolism Disorders Through Modulation of HMG-CoA Reductase, Apo A-1, PCSK-9, p-AMPK, SREBP-2, and CYP2E1 Expression.

本文引用的文献

1
Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study.抗糖尿病药和抗高血压药物在摩洛哥的使用:一项药物流行病学描述性研究。
Afr J Prim Health Care Fam Med. 2020 Jun 15;12(1):e1-e6. doi: 10.4102/phcfm.v12i1.2195.
2
Prevalence, control and risk factors related to hypertension among Moroccan adults: a multicentre study.摩洛哥成年人高血压的患病率、控制率及相关危险因素:一项多中心研究。
East Mediterr Health J. 2019 Oct 4;25(7):447-456. doi: 10.26719/emhj.18.057.
3
[Inferior myocardial infarction: first Moroccan study of 103 cases].
叶下珠提取物通过调节HMG-CoA还原酶、载脂蛋白A-1、前蛋白转化酶枯草溶菌素9、磷酸化腺苷酸活化蛋白激酶、固醇调节元件结合蛋白2和细胞色素P450 2E1的表达对脂质代谢紊乱的影响
Metabolites. 2024 Dec 23;14(12):728. doi: 10.3390/metabo14120728.
4
Cardiovascular risk factors in Moroccan women: systematic review and meta-analysis.摩洛哥女性心血管危险因素:系统评价和荟萃分析。
BMC Public Health. 2024 Sep 3;24(1):2390. doi: 10.1186/s12889-024-19950-4.
5
Knowledge, attitudes, and practices of cardiac rehabilitation among physiotherapists in Morocco.摩洛哥物理治疗师对心脏康复的知识、态度和实践
Glob Cardiol Sci Pract. 2024 Apr 20;2024(3):e202423. doi: 10.21542/gcsp.2024.23.
6
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study.射血分数降低或轻度降低的心力衰竭患者死亡率的预测因素:卡萨布兰卡心力衰竭研究
Egypt Heart J. 2024 Jan 22;76(1):5. doi: 10.1186/s43044-024-00436-y.
7
Genetically predicted cardiovascular diseases could increase the risk of erectile dysfunction: a bidirectional Mendelian randomization.遗传预测的心血管疾病可能会增加勃起功能障碍的风险:一项双向孟德尔随机化研究。
World J Urol. 2023 Nov;41(11):3187-3194. doi: 10.1007/s00345-023-04630-6. Epub 2023 Oct 2.
8
The national moroccan registry of ST-elevation myocardial infarction (MR-MI).摩洛哥国家 ST 段抬高型心肌梗死注册登记研究(MR-MI)。
BMC Cardiovasc Disord. 2023 Aug 24;23(1):419. doi: 10.1186/s12872-023-03458-7.
9
Morocco's Healthcare System: Achievements, Challenges, and Perspectives.摩洛哥的医疗保健系统:成就、挑战与展望。
Cureus. 2023 Jun 29;15(6):e41143. doi: 10.7759/cureus.41143. eCollection 2023 Jun.
[下壁心肌梗死:摩洛哥对103例病例的首次研究]
Pan Afr Med J. 2019 May 31;33:74. doi: 10.11604/pamj.2019.33.74.16047. eCollection 2019.
4
Anthropometric status and body image perception among Moroccan university students.摩洛哥大学生的人体测量状况与身体形象认知
Rev Epidemiol Sante Publique. 2019 Sep;67(5):311-317. doi: 10.1016/j.respe.2019.04.057. Epub 2019 Jul 16.
5
The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM).中东北非地区 2 型糖尿病患者在斋月期间的特征和护理模式:一项国际前瞻性研究(DAR-MENA T2DM)。
Diabetes Res Clin Pract. 2019 May;151:275-284. doi: 10.1016/j.diabres.2019.02.020. Epub 2019 Feb 27.
6
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
7
Objectively Measured Physical Activity and Sedentary Time among Children and Adolescents in Morocco: A Cross-Sectional Study.摩洛哥儿童和青少年的客观体力活动和久坐时间:一项横断面研究。
Biomed Res Int. 2018 Sep 26;2018:8949757. doi: 10.1155/2018/8949757. eCollection 2018.
8
Association of Obesity and Socioeconomic Status among Women of Childbearing Age Living in Urban Area of Morocco.摩洛哥城市地区育龄妇女肥胖与社会经济地位之间的关联。
J Nutr Metab. 2018 Jul 29;2018:6043042. doi: 10.1155/2018/6043042. eCollection 2018.
9
Prevalence of and risk factors for overweight and obesity among adolescents in Morocco.摩洛哥青少年超重和肥胖的患病率及风险因素
East Mediterr Health J. 2018 Jul 29;24(6):512-521. doi: 10.26719/2018.24.6.512.
10
Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.将世界卫生组织基本药物清单现代化以预防和控制心血管疾病。
J Am Coll Cardiol. 2018 Feb 6;71(5):564-574. doi: 10.1016/j.jacc.2017.11.056.